https://www.selleckchem.com/pr....oducts/atuzabrutinib
The utilization of a wide spectrum of nonhost resistances can also be adopted once practical methods have been developed. In gastroesophageal reflux disease (GERD), the additive effect of mosapride to a proton pump inhibitor (PPI) is still controversial. This meta-analysis integrated randomized controlled trials (RCTs) in which mosapride combined with a PPI was compared with a PPI alone in GERD treatment. RCTs were systematically searched with the PubMed, Cochrane library, Web of Science, and the Igaku-Chuo-Zasshi database. We com
Like
Comment
Share
